Are you curious about groundbreaking therapies for joint pain in hypogonadal men (low testosterone)? Tune in to our latest podcast episode, where we dive into a fascinating pilot study exploring the benefits of nandrolone decanoate (ND). Learn how this FDA-approved testosterone derivative not only reduces pain scores by an average of 44% but also helps decrease the need for pain medications—a vital step in addressing the opioid crisis. Our expert guests unpack the study’s methodology, discuss real-world implications, and explore what’s next for nandrolone in treating joint pain. Don’t miss this insightful conversation about a potential game-changer in men’s health!